Remote versus in-person 30-second sit-to-stand testing for people with peripheral artery disease
Consistency Between Tele-Assessment and Face-to-Face Assessment Results of the 30-Second Sit-to-Stand Test in Patients With Peripheral Arterial Disease
This project will test whether doing the 30-second sit-to-stand test by video works as well as doing it in person for adults aged 18–65 with Fontaine stage I–II peripheral artery disease who have a smartphone.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 45 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Izmir Democracy University Academic / other |
| Locations | 1 site (Izmir, Balçova) |
| Trial ID | NCT07497360 on ClinicalTrials.gov |
What this trial studies
This observational study compares telemedicine and face-to-face administration of the 30-second sit-to-stand test in adults with peripheral artery disease (Fontaine I–II). Participants who meet inclusion criteria perform the standardized 30-second sit-to-stand test both remotely via smartphone video and in person at the Izmir clinic, and results are compared for agreement, reliability, and feasibility. The protocol excludes individuals with conditions that limit standing or walking, recent major cardiac events, or inability to use a smartphone. Findings will inform whether remote functional testing can be used to monitor strength and mobility and guide rehabilitation without requiring clinic visits.
Who should consider this trial
Good fit: Adults aged 18–65 with PAD Fontaine stage I–II confirmed by imaging who can stand, cooperate, and have a smartphone with internet access.
Not a fit: People with advanced PAD (Fontaine III–IV), recent major surgery or myocardial infarction, severe cardiopulmonary disease, amputations, use of walking aids, or without smartphone/internet are unlikely to benefit from the tele-assessment approach evaluated here.
Why it matters
Potential benefit: If remote testing matches in-person results, patients could be monitored and guided for rehabilitation at home, reducing travel and improving access to care.
How similar studies have performed: Telemedicine delivery of functional tests, including sit-to-stand, has shown reasonable reliability in older adults and other chronic conditions, but evidence specifically in PAD is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged between 18 and 65 years * Diagnosed with peripheral artery disease, Fontaine stage I-II, confirmed by peripheral angiography or Doppler ultrasonography * Willingness to participate in the study * Access to a smartphone and the internet Exclusion Criteria: * Presence of orthopedic, neurological, or psychological conditions that limit physical activity * Neurological or musculoskeletal disorders affecting standing or walking * History of ischemic amputation * Acute inflammatory condition * Use of walking aids * Visual or hearing impairment * Vestibular system disorder * Cognitive impairment affecting cooperation * Severe cardiopulmonary diseases limiting walking ability * Major surgery or myocardial infarction within the last three months * Unstable coronary artery disease
Where this trial is running
Izmir, Balçova
- Dokuz Eylul University Faculty of Medicine — Izmir, Balçova, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Hazal Yakut Ozdemir, PhD
- Email: hazal.yakutozdemir@idu.edu.tr
- Phone: +9005074825877
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.